Developments in psoriasis and psoriatic arthritis


Autoria(s): Feletar, M.; Foley, P.; Brown, Matthew A.
Data(s)

2008

Resumo

Psoriasis and psoriatic arthritis are common conditions for which treatment options have until recently been extremely limited. Recent advances in our understanding of the immunology and genetics underlying these conditions have been rapid, and have contributed to the development of new therapies for these diseases. This article discusses the current state of the art in our understanding of the aetiopathogenesis of psoriasis and psoriatic arthritis, and current therapies for the diseases.

Identificador

http://eprints.qut.edu.au/89419/

Publicador

Elsevier Ltd.

Relação

DOI:10.1016/j.ddmec.2008.05.001

Feletar, M., Foley, P., & Brown, Matthew A. (2008) Developments in psoriasis and psoriatic arthritis. Drug Discovery Today: Disease Mechanisms, 5(1), e47-e54.

Direitos

Copyright 2008 Elsevier Ltd.

Fonte

Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #abatacept #adalimumab #alefacept #calcipotriol #cyclosporin #dihydrofolate reductase #dihydroorotate dehydrogenase #efalizumab #endothelial leukocyte adhesion molecule 1 #etanercept #etretin #etretinate #golimumab #HLA antigen #infliximab #intercellular adhesion molecule 1 #interleukin 12 #interleukin 12p40 #interleukin 15 #interleukin 23 #interleukin 23 receptor #leflunomide #methotrexate #placebo #rituximab #rosiglitazone #tazarotene #ustekinumab #vitamin D #adaptive immunity #cell differentiation #cell proliferation #clinical trial #disease classification #environmental factor #enzyme inhibition #genetic association #genetic predisposition #genetics #human #immunology #immunopathology #inhibition kinetics #innate immunity #keratinocyte #medical decision making #pathogenesis #phototherapy #psoriasis #psoriasis vulgaris #psoriatic arthritis #PUVA #review #rheumatoid arthritis #systemic lupus erythematosus
Tipo

Journal Article